Excellent
Aligned
Patient Risk:
Low
Summary
The AI response concludes the claim “WARNING: SERIOUS SKIN RASHES” is supported and cites consistent, explicit SUBVENITE boxed warning/section 5.1 text including hospitalization, discontinuation, serious rashes, and guidance to discontinue at first sign of rash.
Category Scores
Accurate Statements
“WARNING: SERIOUS SKIN RASHES” is supported by the prescribing information.
Label section 5.1 “Serious Skin Rashes [see Boxed Warning]” states SUBVENITE can cause serious rashes requiring hospitalization and discontinuation, includes Stevens-Johnson syndrome/toxic epidermal necrolysis/rash-related death, and instructs discontinuation at the first sign of rash unless clearly not drug related.
The product includes a boxed warning/label section titled “Serious Skin Rashes.”
Label section header: “5.1 Serious Skin Rashes [see Boxed Warning]” and boxed warning content referenced therein.
The label describes hospitalization and discontinuation due to serious rashes.
“SUBVENITE can cause serious rashes requiring hospitalization and discontinuation of treatment.” (5.1)
The label includes severe reactions such as Stevens-Johnson syndrome and mentions toxic epidermal necrolysis/rash-related death.
5.1: “Stevens-Johnson syndrome” and “rare cases of toxic epidermal necrolysis and/or rash-related death have been reported…”
The label instructs discontinuing at the first sign of rash unless the rash is clearly not drug related.
5.1: “Accordingly, SUBVENITE should ordinarily be discontinued at the first sign of rash, unless the rash is clearly not drug related.”
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The response only evaluates label support for a boxed warning and does not provide dosing or treatment instructions beyond what is directly supported in the cited boxed warning/section 5.1 text.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Aligned
Primary Issue
Suggested Improvement